Vaxxel
Platform for intranasal vaccine candidates preventing pneumovirus infections.
1
Funding Rounds
$1.3m
Money raised
Overview
Platform for intranasal vaccine candidates preventing pneumovirus infections.
- Website:
- Business model: B2B
- Headquarters: Lyon
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Vaxxel has raised a total of $1.3m in funding over 1 rounds.
Key Insights:
- Vaxxel March 2022 Seed Funding Round: $1.3m
Vaxxel March 2022 Seed Funding Round
$1.3m
Industries
Vaxxel is active in the following industries: